Expected Rebound in Elective and Medically Necessary Procedures

Expected Rebound in Elective and Medically Necessary Procedures

Rafi Musher • May 26, 2020
Rafi Musher • May 26, 2020

Share

Stax's short term outlook (1-6 month) across the healthcare sector.

Many healthcare companies have similar questions about return to patient volumes, which locations will see a return to procedures, and the long-term prognosis for healthcare. To facilitate the process and speed up the effort, Stax has initiated new field research on expectations for return to procedures and developed a fast framework to help management teams, boards of directors, and investors determine the short, medium, and long- term implications for healthcare and their particular organizations.


The process is informed by 20 years of providing healthcare leaders with insights for strategic operating and investment decisions. It is inclusive, iterative, data-rich, and can be done remotely.


With a 20+ year record of successfully modeling healthcare volumes, supply and demand, and competitive market dynamics across the spectrum of providers, we know how public and private spend can be modeled to help forecast overall patient volumes nationally and locally. We have a range of traditional and creative datasets at our fingertips and understand how to conduct large-scale primary research with consumers, healthcare professionals, and providers. Healthcare choices are complex, and there is a tremendous amount of data to bring together and model to provide strong parameters on patient volumes and market share potential, for management teams and investors for the short and long term.




Contact Us

Read More

What Local Governments Need from GovTech Right Now: Lessons from CivStart
By Chen Liu • October 1, 2026
Partner Chen Liu attended CivStart's GovTech conference, sharing his insights and key takeaways on what GovTech providers and investors should know. Read more.
Grant Thornton Stax Top 20 2025
By Florent Jarry & David Lindsay • September 17, 2026
Grant Thornton Stax has released its annual Top 20 Ranking of Exhibition Organizers. Click here to explore the full list.
Feat. by Pitchbook: The future of diligence is not integration. It is conviction.
By Paul Edwards • September 15, 2026
Global Practice Leader Paul Edwards explains how diligence is changing and how confidence and conviction are adding exit value. Read the full article here.
Featured by Carta: PE is trying to figure out where AI fits into the future of healthcare
By Rob Larson • September 8, 2026
Rob Larson met with Carta to discuss the growing problem of supply and demand in the US healthcare system, and how a technological revamp could be necessary. Read the full feature here.
Grant Thornton Stax  Sell-side: Outcomes Strategic Investment From H.I.G. Capital
September 2, 2026
Grant Thornton Stax supported Outcomes, a leading provider of clinical network services and pharmacy technology, on its recent acquisition by H.I.G. Capital. Read more.
Grant Thornton Stax Advises AirPro & Rotunda Capital on Merger with Revv
August 24, 2026
Grant Thornton Stax supported AirPro Diagnostics and Rotunda Capital Partners on AirPro's recent merger with Revv, a leading AI-powered OS for ADAS automotive repair workflows. Read more.
Show More